247 related articles for article (PubMed ID: 24246620)
1. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma.
Gupta S; Khan S; Kawka M; Gujjuri R; Chau I; Starling N; Cunningham D; Jiao LR; Gall T
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1159-1167. PubMed ID: 34402366
[TBL] [Abstract][Full Text] [Related]
5. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma.
Li Q; Wang J; Juzi JT; Sun Y; Zheng H; Cui Y; Li H; Hao X
J Gastrointest Surg; 2008 Sep; 12(9):1540-7. PubMed ID: 18629593
[TBL] [Abstract][Full Text] [Related]
6. Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence.
Horigome H; Nomura T; Nakao H; Saso K; Takahashi Y; Akita S; Sobue S; Mizuno Y; Nojiri S; Hirose A; Masuko K; Murasaki G; Fujino N; Nakahara R; Ichikawa T; Itoh M
Hepatogastroenterology; 2000; 47(32):507-11. PubMed ID: 10791223
[TBL] [Abstract][Full Text] [Related]
7. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
8. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
Minagawa M; Makuuchi M; Takayama T; Kokudo N
Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
[TBL] [Abstract][Full Text] [Related]
9. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
10. Clonal Origin of Hepatocellular Carcinoma and Recurrence After Liver Transplantation.
Wang Z; Gong W; Shou D; Zhang L; Gu X; Wang Y; Teng D; Zheng H
Ann Transplant; 2016 Aug; 21():484-90. PubMed ID: 27487734
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
Hepatogastroenterology; 2015; 62(138):399-404. PubMed ID: 25916071
[TBL] [Abstract][Full Text] [Related]
13. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
Poon RT; Fan ST; Ng IO; Lo CM; Liu CL; Wong J
Cancer; 2000 Aug; 89(3):500-7. PubMed ID: 10931448
[TBL] [Abstract][Full Text] [Related]
14. [Recurrent hepatocellular carcinoma after hepatic resection].
Segawa T; Izawa K; Ichinose Y; Tsunoda T; Tsuchiya R; Kanematsu T
Nihon Geka Gakkai Zasshi; 1992 Jul; 93(7):723-30. PubMed ID: 1324396
[TBL] [Abstract][Full Text] [Related]
15. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
[TBL] [Abstract][Full Text] [Related]
16. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas.
Nagano Y; Shimada H; Ueda M; Matsuo K; Tanaka K; Endo I; Kunisaki C; Togo S
ANZ J Surg; 2009 Oct; 79(10):729-33. PubMed ID: 19878169
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.
Wang J; Li Q; Sun Y; Zheng H; Cui Y; Li H; Zhou H; Hao X
Surg Oncol; 2009 Mar; 18(1):25-30. PubMed ID: 18640032
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model.
Yin XY; Xie XY; Lu MD; Kuang M; Liu GJ; Xu ZF; Xu HX; Wang Z
Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
